Clinical Trials Browser

Gastroesophageal Adenocarcinoma × durvalumab × Gastrointestinal × Clear all

NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Phase 1 Recruiting

Gastrointestinal

Gastroesophageal Adenocarcinoma